Canton Strategic Holdings (CNTN) Net Income towards Common Stockholders Growth (3y) (2024 - 2026)
Canton Strategic Holdings (CNTN) Net Income towards Common Stockholders Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -10.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 26.38% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 34.98% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -46.86% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -160.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -160.17% |
| Dec 31, 2025 | -9.72% |
| Sep 30, 2025 | 0.40% |
| Jun 30, 2025 | -4.26% |
| Mar 31, 2025 | 4.86% |
| Dec 31, 2024 | -119.19% |
| Sep 30, 2024 | -69.67% |
| Jun 30, 2024 | -21.80% |
| Mar 31, 2024 | -11.77% |